Nicotinamide Mononucleotide with L-Leucine: Clinical Trials

1 trial of Nicotinamide Mononucleotide with L-Leucine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Terminated 1

Follow Nicotinamide Mononucleotide with L-Leucine: new trials by email Literature Review of Nicotinamide Mononucleotide with L-Leucine trials Research Report on Nicotinamide Mononucleotide with L-Leucine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the Effect of Nicotinamide Mononucleotide (NMN) As an Adjuvant to Standard of Care (SOC) On Fatigue Associated With COVID-19 Infection
Nicotinamide Mononucleotide, Nicotinamide Mononucleotide with L-Leucine, Placebo - COVID-19 Infection
Not applicableTerminatedVedic Lifesciences Pvt. Ltd.692021-12-272024-09-23

Conditions studied

COVID-19 (1)

Sponsors

Vedic Lifesciences Pvt. Ltd. (1)

Countries

India (1)